A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa

Peptides

Volumn 28, Issue 3, 2007, Pages 560-565

  Wang, Jianbin ^a   Wang, H X ^b   Ng, T B ^c  

^a PEKING UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

AIDS; Edible and medicinal mushrooms; HIV; Purification; Reverse transcriptase (RT)

Indexed keywords

AMINO ACID; DIETHYLAMINOETHYL CELLULOSE; HOT WATER; LACCASE; LYSYLARGINYLGLUTAMYLHISTIDYLGLYCYLGLUTAMINYLHISTIDYLCYSTEINYL GLUTAMYLPHENYLALANINE; PEPTIDE; PROTEINASE; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANION EXCHANGE CHROMATOGRAPHY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EDIBLE MUSHROOM; ENZYME ACTIVITY; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; IC 50; MOLECULAR WEIGHT; MUSHROOM; NONHUMAN; PLEUROTUS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEINASE INHIBITION; SCREENING; TRAMETES;

AGARICALES; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; FUNGAL PROTEINS; HIV-1 REVERSE TRANSCRIPTASE; PEPTIDES; REVERSE TRANSCRIPTASE INHIBITORS;

BASIDIOMYCOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; LACTARIUS CAMPHORATUS; PLEUROTUS PULMONARIUS; PLEUROTUS SAJOR-CAJU; RUSSULA PALUDOSA; SPARASSIS CRISPA; TRAMETES SUAVEOLENS;

EID: 33846837387     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.10.004     Document Type: Article

References (35)

1. Agrawal L., Lu X.H., Jin Q.W., and Alkhatib G. Anti-HIV therapy: current and future directions. Curr Pharm Des 12 (2006) 2031-2055
2. Azad A.A. Novel drugs and vaccines based on the structure and function of HIV pathogenic proteins including Nef. Natural products and molecular therapy. Ann N Y Acad Sci 1056 (2005) 279-292
3. Bourinbaiar A.S., and Jirathitika V. Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries. Curr Pharm Des 9 (2003) 1419-1431
4. Cook J.E., Dasgupta S., Middaugh L.D., Terry E.C., Gorry P.R., Wesselingh S.L., et al. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann Neurol 57 (2005) 795-803
5. Ghafouri M., Amini S., Khalili K., and Sawaya B.E. HIV-1 associated dementia: symptoms and causes. Retrovirol 3 (2006) [Art. No. 28]
6. Honda M., and Oka S. Current therapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Int J Hematol 84 (2006) 18-22
7. Joseph E., Yeni P., Gathe J., Estrada V., DeJesus E., Staszewski S., et al. The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial. Lancet 368 (2006) 476-482
8. Kumar N.S., and Pinto B.M. Synthesis of thioswainsonine as a potential glycosidase inhibitor. Carbohydr Res 341 (2006) 1685-1691
9. Liu Q.H., Wang H.X., and Ng T.B. Isolation and characterization of a novel lectin from the wild mushroom Xerocomus spadiceus. Peptides 25 (2004) 7-10
10. Mallery S.R., Clark Y.M., Ness G.M., Minshawi O.M., Pei P., and Hohl C.M. Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells. J Cell Biochem 73 (1999) 259-277
11. Metobo S.E., Jin H.L., Tsiang M., and Kim C.U. Design, synthesis and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring. Bioorg Med Chem Lett 16 (2006) 3985-3988
12. Ng T.B., Au T.K., Lam T.L., Ye X.Y., and Wan D.C. Inhibitory effects of antifungal proteins on human immunodeficiency virus type 1 reverse transcriptase, protease and integrase. Life Sci 70 (2002) 927-935
13. Ng T.B., Huang B., Fong W.P., and Yeung H.W. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors. Life Sci 61 (1997) 933-949
14. Ng T.B., Lam S.K., and Fong W.P. A homodimeric sporamin-type trypsin inhibitor with antiproliferative, HIV reverse transcriptase inhibitory and antifungal activities from wampee (Clausena lansium) seeds. Biol Chem 384 (2003) 289-293
15. Ng T.B., Lam T.L., Au T.K., Ye X.Y., and Wan C.C. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins. Life Sci 69 (2001) 2217-2223
16. Ng T.B., and Wang H.X. Panaxagin, a new protein from Chinese ginseng possesses anti-fungal, anti-viral, translation-inhibiting and ribonuclease activities. Life Sci 68 (2001) 739-749
17. Ng T.B., and Wang H.X. A homodimeric laccase with unqiue characteristics from the yellow mushroom Cantharellus cibarius. Biochem Biophys Res Commun 313 (2004) 37-41
18. Ngai P.H., and Ng T.B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemic cells. Life Sci 73 (2003) 3363-3374
19. Nielsen T.B., and Reynolds J.A. Measurements of molecular weights by gel electrophoresis. Methods Enzymol 48 (1978) 3-10
20. Pienaar E.D., Young T., and Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database System Rev 3 (2006) [Art. No. CD003940]
21. Rumbaugh J.A., and Nath A. Developments in HIV neuropathogenesis. Curr Pharm Des 12 (2006) 1023-1044
22. Sharma P.L., Nurpeisov V., Hernandez-Santiago B., Beltran T., and Schinazi R.F. Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Curr Top Med Chem 4 (2004) 895-919
23. Sticht J., Humbert M., Findlow S., Bodem J., Muller M., Dietrich U., et al. A peptide inhibitor of HIV-1 assembly in vitro. Nat Struct Mol Biol 12 (2005) 671-677
24. Spano J.P., Carcelain G., Katlama C., and Costagliola D. Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives. Bull Cancer 93 (2006) 37-42
25. Vogt V.M. Blocking HIV-1 virus assembly. Nat Struct Mol Biol 12 (2005) 638-639
26. Wang H.X., and Ng T.B. Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translation-inhibitory, and ribonuclease activities. Biochem Biophys Res Commun 276 (2000) 587-593
27. Wang H.X., and Ng T.B. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med 67 (2001) 669-672
28. Wang H.X., Ng T.B., and Pleureryn. a novel protease from fresh fruiting bodies of the edible mushroom Pleurotus eryngii. Biochem Biophys Res Commun 289 (2001) 750-755
29. Wang H.X., and Ng T.B. Ascalin, a new anti-fungal peptide with human immunodeficiency virus type 1 reverse transcriptase-inhibiting activity from shallot bulbs. Peptides 23 (2002) 1025-1029
30. Wang H.X., and Ng T.B. Isolation of a ribonuclease from fruiting bodies of the wild mushroom Termitomyces globulus. Peptides 24 (2003) 973-977
31. Wang H.X., and Ng T.B. Purification of a novel low molecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum. Biochem Biophys Res Commun 315 (2004) 450-454
32. Wang H.X., and Ng T.B. A new ribonuclease from the black oyster mushroom Pleurotus ostreatus. Peptides 25 (2004) 685-687
33. Wang H.X., Ng T.B., and Liu Q.H. Alveolarin, a novel antifungal polypeptide from the wild mushroom Polyporus alveolaris. Peptides 25 (2004) 693-696
34. Wang H.X., and Ng T.B. Isolation of a new ribonuclease from fruiting bodies of the silver plate mushroom Clitocybe maxima. Peptides 25 (2004) 935-939
35. Wang H.X., Ng T.B., Ooi V.E.C., Liu W.K., and Chang S.T. A polysaccharide-peptide complex from cultured mycelia of the mushroom Tricholoma mongolicum with immunoenhancing and antitumor activities. Biochem Cell Biol. 74 (1996) 95-100